| OMEX |
ODYSSEY MARINE EXPLORATION INC |
Common Stock, par value $0.0001 per share |
10% |
$9,915,522 |
+$3,763,646 |
5,084,883 |
+61% |
Two Seas Capital LP |
30 Sep 2025 |
| GCI |
Gannett Co., Inc. |
Common Stock, par value $0.01 per share |
9.6% |
$58,565,965 |
+$12,183,500 |
14,180,621 |
+26% |
Two Seas Capital LP |
30 Sep 2025 |
| CLMT |
Calumet, Inc. |
Common Stock, par value $0.01 per share |
9.3% |
$161,073,775 |
+$26,765,794 |
8,098,229 |
+20% |
Two Seas Capital LP |
31 Dec 2025 |
| MDRX |
Veradigm Inc. |
Common Stock, par value $0.01 per share |
6.9% |
$36,229,165 |
+$7,986,025 |
7,469,931 |
+28% |
Two Seas Capital LP |
31 Dec 2025 |
| CORZ |
Core Scientific, Inc. |
Common Stock, par value $0.00001 per share |
6.7% |
$389,944,272 |
-$33,437,006 |
20,697,679 |
-7.9% |
Two Seas Capital LP |
18 Feb 2026 |
| ABUS |
Arbutus Biopharma Corp |
Common Shares, without par value |
6.5% |
$59,672,609 |
+$10,171,286 |
12,589,158 |
+21% |
Two Seas Capital LP |
31 Dec 2025 |
| INDV |
INDIVIOR PLC |
Ordinary Shares, $0.50 nominal value per share |
5% |
$203,438,218 |
-$27,837,500 |
6,211,854 |
-12% |
Two Seas Capital LP |
23 Dec 2025 |
| ESPR |
Esperion Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
4.7% |
$25,836,769 |
-$543,915 |
9,749,724 |
-2.1% |
Two Seas Capital LP |
30 Sep 2025 |
| AVDL |
AVADEL PHARMACEUTICALS PLC |
Ordinary Shares, nominal value $0.01 per share |
0% |
$0 |
-$132,210,990 |
0 |
-100% |
Two Seas Capital LP |
31 Dec 2025 |
| ADAP |
Adaptimmune Therapeutics PLC |
Ordinary Shares, par value GBP 0.001 per share |
0% |
$0 |
-$17,612,947 |
0 |
-100% |
Two Seas Capital LP |
30 Sep 2025 |